China Digest: Asymchem Labs lines up $558m R&D hub; Ubrigene notches Series C funding

China Digest: Asymchem Labs lines up $558m R&D hub; Ubrigene notches Series C funding

Photo by National Cancer Institute on Unsplash

Stephanie Li

27 September, 2022

Asymchem LaboratoriesAsymchem Laboratories (Tianjin) Co. LtdHillhouse Capital Group

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.